At a recent European Commission hearing on Future Patent Policy In Europe, stakeholders’ views on the patent system in Europe were examined. Participants called for more centralization in terms of a single patent system or a common litigation system but there was plenty of dissent. This was the second step of the public consultation with […]

After the Medicines Company, based in Massachusetts, missed a non-extendable deadline for filing for a patent term extension by a single day, Rep William Jenkins [TN] introduced H.R. 5120 in the U.S. House of Representatives to amend 35 U.S.C. 156, the statute governing patent term extensions based on regulatory review delay. Known as the “Dog […]

As I was scrolling through i-Tunes looking for some summer music to download, I happened to come across the song “Buttons” at almost the same time the news reports had come on reporting that the Senate, in a 63-37 vote, gave final approval to expanding federal funding for embryonic stem-cell research, which many scientists believe […]

The Federal Circuit has held that a licensee in good standing cannot bring suit in federal court seeking a declaration that the licensed patent is invalid or unenforceable. I think that’s right, and I’ve written an amicus brief that I am writing on behalf of law professors (mostly IP types) to file with the Supreme […]

In his official capacity as Director of the USPTO, Jon Dudas, along with Yeda Research and Development Co., was recently named as a defendant in an action filed by Enzo Therapeutics. The complaint, filed July 3 in the U.S. District Court for the Eastern District of Virginia, details Enzo’s unsuccessful efforts to establish co-pendency of […]

In a bit of shameless self-promotion, we simply must announce that the Patent Baristas were ranked (again!) in the 2006 Edition of Chambers USA, a publication that ranks attorneys and their practices based upon peer and client review. Chambers USA touts the Intellectual Property Department as known for their “exceptional” attention to detail and impeccable […]

As part of its ongoing efforts to reduce its workload instead of expanding to meet increased demand, the U.S. Patent and Trademark Office (USPTO) announced a new proposal for the patent application review process. Under the new proposal, patent applicants would be required to provide the USPTO with the most relevant information related to their […]

The University of Alabama in Huntsville (UAH) announced the settlement of their suit against Nektar Therapeutics and Dr. Milton Harris, the founder of Nektar Alabama and a former employee of UAH, in exchange for a total cash payment of $25 million. Under the terms of the agreement, Nektar and Dr. Harris have jointly made an […]